Grove Biopharma
Grove Biopharma is a Chicago-based biopharmaceutical company developing therapeutics that target intracellular protein-protein interactions implicated in cancer, neurodegenerative diseases, and rare disorders. The company pioneered Bionic Biologics, hybrid biomolecules that integrate principles of biologic and synthetic design to achieve cell permeability with customizable, modular construction that can disrupt or degrade disease-causing proteins. Grove has demonstrated proof-of-concept against targets including AR/AR-V7, SHOC2, MYC, TAU, and KEAP1/NRF2. Founded in 2025 and led by CEO Geoffrey Duyk, the company raised a $30M Series A in April 2025 and is backed by DCVC. Grove is a therapeutics company with no public developer API surface; this profile captures its identity for the API Evangelist network.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Grove Biopharma is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Grove Biopharma scores 6.1/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
Resources
Every other property we hold for Grove Biopharma — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Company 5
The organization behind the API
Grove Biopharma is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/grove-biopharma · machine-readable index on apis.io